U.S. markets closed

Gene Biotherapeutics, Inc. (CRXM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0374-0.0001 (-0.27%)
At close: 2:59PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 11/28/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 3-71.43%
S&P500 52-Week Change 317.96%
52 Week High 30.1900
52 Week Low 30.0200
50-Day Moving Average 30.0509
200-Day Moving Average 30.0685

Share Statistics

Avg Vol (3 month) 3371.8k
Avg Vol (10 day) 3545.81k
Shares Outstanding 514.37M
Float 12.78M
% Held by Insiders 111.07%
% Held by Institutions 10.02%
Shares Short (Dec 30, 2013) 4150.25k
Short Ratio (Dec 30, 2013) 41.03
Short % of Float (Dec 30, 2013) 42.47%
Short % of Shares Outstanding (Dec 30, 2013) 41.71%
Shares Short (prior month Nov 28, 2013) 4448.45k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jul 17, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2016
Most Recent Quarter (mrq)Mar 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-758.60%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-3.85M
Diluted EPS (ttm)-0.2850
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)176.37k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)1.05M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.26

Cash Flow Statement

Operating Cash Flow (ttm)-2.52M
Levered Free Cash Flow (ttm)-1.47M